"Nasling" prognostic gene imprinting detection system for breast cancer - Taiwan Registration f5ff0d2a9d323e0aa613b2ad66e72ca3

Access comprehensive regulatory information for "Nasling" prognostic gene imprinting detection system for breast cancer in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f5ff0d2a9d323e0aa613b2ad66e72ca3 and manufactured by VERACYTE, INC.;; Veracyte. The authorized representative in Taiwan is COLD SPRING BIOTECH CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.